Literature DB >> 19422383

Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress.

M Spite1, L Summers, T F Porter, S Srivastava, A Bhatnagar, C N Serhan.   

Abstract

BACKGROUND AND
PURPOSE: Inflammation is associated with oxidative stress and local generation of lipid peroxidation-derived aldehydes, such as 4-hydroxy-trans-2-nonenal (HNE). In most tissues, HNE is readily conjugated with glutathione and presently it is unknown whether glutathionyl-HNE (GS-HNE) plays a functional role in inflammation. Here, we sought to determine whether GS-HNE is a mediator of oxidative stress-initiated inflammation and if its actions can be regulated by the anti-inflammatory and pro-resolving lipid mediator, resolvin D1 (RvD1). EXPERIMENTAL APPROACH: GS-HNE was administered intraperitoneally to mice and peritoneal lavages were assessed for leukocyte infiltration and lipid mediators were targeted by mediator-lipidomics. RvD1 was administered to mice treated with GS-HNE and leukocyte infiltration was assessed in the peritoneum. Superoxide production and CD11b modulation were measured in isolated human polymorphonuclear leukocytes incubated with GS-HNE. KEY
RESULTS: GS-HNE (1-10 microg) evoked infiltration of Gr-1(+) leukocytes into the peritoneum to form an inflammatory exudate. With isolated human polymorphonuclear leukocytes, GS-HNE stimulated both superoxide generation and CD11b expression. Among the lipid mediators, both cyclooxygenase- and lipoxygenase-derived pro-inflammatory eicosanoids, including prostaglandin E(2), leukotriene B(4) and cysteinyl leukotrienes, were generated in exudates of mice injected intraperitoneally with GS-HNE. RvD1, given i.v. in doses as low as 0.01-10.0 ng, sharply reduced GS-HNE-stimulated leukocyte infiltration ( approximately 30-70%). CONCLUSIONS AND IMPLICATIONS: Glutathione conjugates of HNE, derived during oxidative stress, are pro-inflammatory in vivo. RvD1 protects against this oxidative stress-initiated inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422383      PMCID: PMC2785528          DOI: 10.1111/j.1476-5381.2009.00234.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  A novel glutathione containing eicosanoid (FOG7) chemotactic for human granulocytes.

Authors:  R C Bowers; J Hevko; P M Henson; R C Murphy
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 3.  Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities.

Authors:  G Subbanagounder; A D Watson; J A Berliner
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

4.  Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.

Authors:  S Srivastava; D J Conklin; S Q Liu; N Prakash; P J Boor; S K Srivastava; A Bhatnagar
Journal:  Atherosclerosis       Date:  2001-10       Impact factor: 5.162

5.  Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase.

Authors:  S Srivastava; B L Dixit; J Cai; S Sharma; H E Hurst; A Bhatnagar; S K Srivastava
Journal:  Free Radic Biol Med       Date:  2000-10-01       Impact factor: 7.376

6.  Possible role of aldehydic lipid peroxidation products as chemoattractants.

Authors:  M Curzio; H Esterbauer; G Poli; F Biasi; G Cecchini; C Di Mauro; N Cappello; M U Dianzani
Journal:  Int J Tissue React       Date:  1987

7.  Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids.

Authors:  A Benedetti; M Comporti; H Esterbauer
Journal:  Biochim Biophys Acta       Date:  1980-11-07

8.  The cyclopentenone product of lipid peroxidation, 15-A2t-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione.

Authors:  Ginger L Milne; Giuseppe Zanoni; Alessio Porta; Soumya Sasi; Giovanni Vidari; Erik S Musiek; Michael L Freeman; Jason D Morrow
Journal:  Chem Res Toxicol       Date:  2004-01       Impact factor: 3.739

Review 9.  Intracellular metabolism of 4-hydroxynonenal.

Authors:  Werner Siems; Tilman Grune
Journal:  Mol Aspects Med       Date:  2003 Aug-Oct

10.  Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

Authors:  Charles N Serhan; Song Hong; Karsten Gronert; Sean P Colgan; Pallavi R Devchand; Gudrun Mirick; Rose-Laure Moussignac
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  41 in total

1.  Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception.

Authors:  S Bang; S Yoo; T J Yang; H Cho; Y G Kim; S W Hwang
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 2.  Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.

Authors:  Matthew Spite; Charles N Serhan
Journal:  Circ Res       Date:  2010-11-12       Impact factor: 17.367

3.  Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes.

Authors:  Zhen Gu; Gwyneth J Lamont; Richard J Lamont; Silvia M Uriarte; Huizhi Wang; David A Scott
Journal:  Innate Immun       Date:  2016-02-15       Impact factor: 2.680

4.  Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.

Authors:  Nguyen Dang Hung; Mee Ree Kim; Dai-Eun Sok
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

5.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

Review 6.  Novel anti-inflammatory--pro-resolving mediators and their receptors.

Authors:  Charles N Serhan; Sriram Krishnamoorthy; Antonio Recchiuti; Nan Chiang
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

7.  D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.

Authors:  Takuya Miyahara; Sara Runge; Anuran Chatterjee; Mian Chen; Giorgio Mottola; Jonathan M Fitzgerald; Charles N Serhan; Michael S Conte
Journal:  FASEB J       Date:  2013-02-13       Impact factor: 5.191

Review 8.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

9.  Resolvin D1 Reduces Emphysema and Chronic Inflammation.

Authors:  Hsi-Min Hsiao; Thomas H Thatcher; Romain A Colas; Charles N Serhan; Richard P Phipps; Patricia J Sime
Journal:  Am J Pathol       Date:  2015-10-24       Impact factor: 4.307

10.  Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.

Authors:  Bangwei Luo; Fuyu Han; Kai Xu; Jinsong Wang; Zongwei Liu; Zigang Shen; Jia Li; Yu Liu; Man Jiang; Zhi-Yuan Zhang; Zhiren Zhang
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.